Modulation of natural killer activity by thymosin alpha 1 and interferon. (Record no. 3857389)

MARC details
000 -LEADER
fixed length control field 01387 a2200409 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250512074321.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 198601s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0340-7004
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/BF00205574
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Favalli, C
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19860102
245 00 - TITLE STATEMENT
Title Modulation of natural killer activity by thymosin alpha 1 and interferon.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer immunology, immunotherapy : CII
Date of publication, distribution, etc. 1985
300 ## - PHYSICAL DESCRIPTION
Extent 189-92 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Animals
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Differentiation
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclophosphamide
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cytotoxicity, Immunologic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunity, Innate
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interferon Type I
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Killer Cells, Natural
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mice
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mice, Inbred C57BL
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Radiation Chimera
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thymalfasin
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thymosin
General subdivision analogs & derivatives
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jezzi, T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mastino, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rinaldi-Garaci, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Riccardi, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Garaci, E
773 0# - HOST ITEM ENTRY
Title Cancer immunology, immunotherapy : CII
Related parts vol. 20
-- no. 3
-- p. 189-92
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/BF00205574">https://doi.org/10.1007/BF00205574</a>
Public note Available from publisher's website

No items available.